-
Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood CancerDaiichi Sankyo2017-11-15 16:45:01Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer
-
Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and LicensingDaiichi Sankyo2019-02-12 08:38:12Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and
-
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer PatientsDaiichi Sankyo2017-10-17 17:45:01Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
-
Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct “JOINUS,” a New Drug Discovery Program Using Drug-Repositioning Compound LibraryDaiichi Sankyo2019-10-15 11:18:08Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct “JOINUS,” a New Drug Discovery Program Using
-
Daiichi Sankyo Announces TaNeDS Global 2018 Collaborative Drug Discovery ProgramDaiichi Sankyo2017-09-26 17:45:01Daiichi Sankyo Announces TaNeDS Global 2018 Collaborative Drug Discovery Program
-
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia TherapiesDaiichi Sankyo2017-12-15 10:30:39MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid
-
Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Medical Oncology (ESMO) 2017 CongressDaiichi Sankyo2017-12-15 10:30:59Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Medical
